Clínic Barcelona

Researchers describe a genetic signature that predicts the response to immunotherapy treatment in liver cancer

In an important breakthrough in precision medicine and for the approval of cost-effective treatments, the expression of eleven genes is found to make it possible to discriminate patients sensitive to PD1 receptor inhibitors in advanced hepatocellular carcinoma.

Josep M. Llovet, leader of the study published in the journal Gastroenterology.

Related contents
Keep reading about: